CAMP4 Debt To Assets vs Ev To Operating Cash Flow Analysis

CAMP Stock

USD 5.41 0.37 6.40%

CAMP4 THERAPEUTICS financial indicator trend analysis is way more than just evaluating CAMP4 THERAPEUTICS prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CAMP4 THERAPEUTICS is a good investment. Please check the relationship between CAMP4 THERAPEUTICS Debt To Assets and its Ev To Operating Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CAMP4 THERAPEUTICS PORATION. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Debt To Assets vs Ev To Operating Cash Flow

Debt To Assets vs Ev To Operating Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CAMP4 THERAPEUTICS Debt To Assets account and Ev To Operating Cash Flow. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between CAMP4 THERAPEUTICS's Debt To Assets and Ev To Operating Cash Flow is -0.31. Overlapping area represents the amount of variation of Debt To Assets that can explain the historical movement of Ev To Operating Cash Flow in the same time period over historical financial statements of CAMP4 THERAPEUTICS PORATION, assuming nothing else is changed. The correlation between historical values of CAMP4 THERAPEUTICS's Debt To Assets and Ev To Operating Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Debt To Assets of CAMP4 THERAPEUTICS PORATION are associated (or correlated) with its Ev To Operating Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ev To Operating Cash Flow has no effect on the direction of Debt To Assets i.e., CAMP4 THERAPEUTICS's Debt To Assets and Ev To Operating Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.31

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Debt To Assets

Ev To Operating Cash Flow

A valuation metric comparing the company's enterprise value to its operating cash flow, indicating how many dollars of EV are generated for each dollar of operating cash flows.

Most indicators from CAMP4 THERAPEUTICS's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CAMP4 THERAPEUTICS current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CAMP4 THERAPEUTICS PORATION. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

At this time, CAMP4 THERAPEUTICS's Selling General Administrative is relatively stable compared to the past year. As of 11/25/2024, Enterprise Value Over EBITDA is likely to grow to 535.90, while Issuance Of Capital Stock is likely to drop 0.00.

	2021	2022	2023	2024 (projected)
Interest Expense	15.3M	6.3M	4.7M	8.3M
Depreciation And Amortization	22.8M	21.8M	19.6M	17.8M

Interest Expense Depreciation And Amortization

CAMP4 THERAPEUTICS fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Common Stock Shares Outstanding
Total Assets		-0.53	-0.16	0.99	0.99	0.97	0.89	-0.73	0.77	0.72	0.85	1.0	0.83	0.82	-0.62	0.94	0.9	0.76	0.91	0.82	0.94	1.0	0.77	0.85	-0.95	-0.94
Short Long Term Debt Total	-0.53		-0.02	-0.51	-0.53	-0.39	-0.34	0.77	-0.05	-0.56	-0.44	-0.54	-0.64	-0.45	0.95	-0.25	-0.52	0.04	-0.67	-0.83	-0.57	-0.52	-0.03	-0.29	0.62	0.44
Other Current Liab	-0.16	-0.02		-0.26	-0.01	-0.02	0.17	-0.36	0.23	-0.72	0.34	-0.19	-0.57	0.37	-0.21	-0.04	-0.57	0.09	-0.43	0.21	-0.37	-0.12	0.19	0.25	0.02	0.0
Total Current Liabilities	0.99	-0.51	-0.26		0.97	0.95	0.86	-0.68	0.74	0.78	0.8	1.0	0.87	0.77	-0.59	0.93	0.93	0.74	0.93	0.77	0.96	0.99	0.74	0.81	-0.93	-0.92
Total Stockholder Equity	0.99	-0.53	-0.01	0.97		0.99	0.93	-0.79	0.83	0.61	0.92	0.98	0.75	0.89	-0.66	0.95	0.82	0.8	0.85	0.85	0.9	0.99	0.82	0.91	-0.96	-0.94
Property Plant And Equipment Net	0.97	-0.39	-0.02	0.95	0.99		0.95	-0.73	0.9	0.56	0.92	0.96	0.69	0.9	-0.55	0.99	0.8	0.88	0.79	0.76	0.88	0.98	0.9	0.94	-0.94	-0.92
Current Deferred Revenue	0.89	-0.34	0.17	0.86	0.93	0.95		-0.78	0.95	0.37	0.96	0.87	0.5	0.95	-0.52	0.92	0.64	0.91	0.65	0.71	0.78	0.91	0.91	0.98	-0.9	-0.87
Net Debt	-0.73	0.77	-0.36	-0.68	-0.79	-0.73	-0.78		-0.62	-0.31	-0.88	-0.71	-0.46	-0.9	0.92	-0.62	-0.5	-0.52	-0.59	-0.89	-0.69	-0.74	-0.59	-0.78	0.87	0.64
Retained Earnings	0.77	-0.05	0.23	0.74	0.83	0.9	0.95	-0.62		0.18	0.91	0.75	0.31	0.9	-0.3	0.91	0.5	0.98	0.45	0.52	0.65	0.8	0.99	0.97	-0.78	-0.77
Accounts Payable	0.72	-0.56	-0.72	0.78	0.61	0.56	0.37	-0.31	0.18		0.27	0.74	0.97	0.24	-0.43	0.52	0.93	0.23	0.93	0.52	0.81	0.69	0.18	0.27	-0.6	-0.61
Cash	0.85	-0.44	0.34	0.8	0.92	0.92	0.96	-0.88	0.91	0.27		0.83	0.43	1.0	-0.66	0.87	0.55	0.84	0.59	0.8	0.73	0.87	0.89	0.98	-0.91	-0.82
Non Current Assets Total	1.0	-0.54	-0.19	1.0	0.98	0.96	0.87	-0.71	0.75	0.74	0.83		0.85	0.8	-0.62	0.94	0.91	0.74	0.92	0.82	0.94	0.99	0.75	0.83	-0.95	-0.93
Non Currrent Assets Other	0.83	-0.64	-0.57	0.87	0.75	0.69	0.5	-0.46	0.31	0.97	0.43	0.85		0.4	-0.56	0.65	0.96	0.33	0.98	0.68	0.87	0.8	0.32	0.42	-0.73	-0.73
Cash And Short Term Investments	0.82	-0.45	0.37	0.77	0.89	0.9	0.95	-0.9	0.9	0.24	1.0	0.8	0.4		-0.67	0.85	0.52	0.83	0.56	0.79	0.71	0.84	0.88	0.97	-0.91	-0.78
Net Receivables	-0.62	0.95	-0.21	-0.59	-0.66	-0.55	-0.52	0.92	-0.3	-0.43	-0.66	-0.62	-0.56	-0.67		-0.42	-0.5	-0.19	-0.63	-0.91	-0.62	-0.62	-0.28	-0.51	0.75	0.53
Good Will	0.94	-0.25	-0.04	0.93	0.95	0.99	0.92	-0.62	0.91	0.52	0.87	0.94	0.65	0.85	-0.42		0.77	0.91	0.75	0.69	0.83	0.95	0.91	0.92	-0.88	-0.92
Non Current Liabilities Total	0.9	-0.52	-0.57	0.93	0.82	0.8	0.64	-0.5	0.5	0.93	0.55	0.91	0.96	0.52	-0.5	0.77		0.54	0.96	0.62	0.96	0.88	0.51	0.58	-0.82	-0.76
Inventory	0.76	0.04	0.09	0.74	0.8	0.88	0.91	-0.52	0.98	0.23	0.84	0.74	0.33	0.83	-0.19	0.91	0.54		0.46	0.42	0.67	0.78	0.99	0.93	-0.75	-0.72
Other Current Assets	0.91	-0.67	-0.43	0.93	0.85	0.79	0.65	-0.59	0.45	0.93	0.59	0.92	0.98	0.56	-0.63	0.75	0.96	0.46		0.77	0.92	0.89	0.45	0.57	-0.83	-0.83
Other Stockholder Equity	0.82	-0.83	0.21	0.77	0.85	0.76	0.71	-0.89	0.52	0.52	0.8	0.82	0.68	0.79	-0.91	0.69	0.62	0.42	0.77		0.7	0.82	0.5	0.69	-0.84	-0.81
Total Liab	0.94	-0.57	-0.37	0.96	0.9	0.88	0.78	-0.69	0.65	0.81	0.73	0.94	0.87	0.71	-0.62	0.83	0.96	0.67	0.92	0.7		0.93	0.66	0.75	-0.94	-0.77
Total Current Assets	1.0	-0.52	-0.12	0.99	0.99	0.98	0.91	-0.74	0.8	0.69	0.87	0.99	0.8	0.84	-0.62	0.95	0.88	0.78	0.89	0.82	0.93		0.79	0.87	-0.95	-0.94
Short Term Debt	0.77	-0.03	0.19	0.74	0.82	0.9	0.91	-0.59	0.99	0.18	0.89	0.75	0.32	0.88	-0.28	0.91	0.51	0.99	0.45	0.5	0.66	0.79		0.96	-0.78	-0.73
Intangible Assets	0.85	-0.29	0.25	0.81	0.91	0.94	0.98	-0.78	0.97	0.27	0.98	0.83	0.42	0.97	-0.51	0.92	0.58	0.93	0.57	0.69	0.75	0.87	0.96		-0.9	-0.81
Common Stock	-0.95	0.62	0.02	-0.93	-0.96	-0.94	-0.9	0.87	-0.78	-0.6	-0.91	-0.95	-0.73	-0.91	0.75	-0.88	-0.82	-0.75	-0.83	-0.84	-0.94	-0.95	-0.78	-0.9		0.83
Common Stock Shares Outstanding	-0.94	0.44	0.0	-0.92	-0.94	-0.92	-0.87	0.64	-0.77	-0.61	-0.82	-0.93	-0.73	-0.78	0.53	-0.92	-0.76	-0.72	-0.83	-0.81	-0.77	-0.94	-0.73	-0.81	0.83

Click cells to compare fundamentals

CAMP4 THERAPEUTICS Account Relationship Matchups

Pair Trading with CAMP4 THERAPEUTICS

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CAMP4 THERAPEUTICS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CAMP4 THERAPEUTICS will appreciate offsetting losses from the drop in the long position's value.

Moving against CAMP4 Stock

0.73	VINC	Vincerx Pharma	Pair Corr
0.51	DTIL	Precision BioSciences	Pair Corr
0.44	DRTS	Alpha Tau Medical	Pair Corr
0.38	DRMA	Dermata Therapeutics	Pair Corr
0.32	VIRX	Viracta Therapeutics	Pair Corr

The ability to find closely correlated positions to CAMP4 THERAPEUTICS could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CAMP4 THERAPEUTICS when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CAMP4 THERAPEUTICS - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CAMP4 THERAPEUTICS PORATION to buy it.

The correlation of CAMP4 THERAPEUTICS is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CAMP4 THERAPEUTICS moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CAMP4 THERAPEUTICS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for CAMP4 THERAPEUTICS can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for CAMP4 Stock Analysis

When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

CAMP4 Debt To Assets vs Ev To Operating Cash Flow Analysis

Debt To Assets vs Ev To Operating Cash Flow

Debt To Assets vs Ev To Operating Cash Flow Correlation Analysis

Correlation Coefficient

Debt To Assets

Ev To Operating Cash Flow

CAMP4 THERAPEUTICS fundamental ratios Correlations

CAMP4 THERAPEUTICS Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Pair Trading with CAMP4 THERAPEUTICS

Moving against CAMP4 Stock

Additional Tools for CAMP4 Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Current Liabilities
Cash And Short Term Investments	+ 1.0	Cash
Total Current Liabilities	+ 0.99	Total Assets
Total Stockholder Equity	+ 0.99	Total Assets

Common Stock	- 0.96	Total Stockholder Equity
Common Stock	- 0.95	Total Current Assets
Common Stock	- 0.95	Non Current Assets Total
Common Stock	- 0.95	Total Assets
Common Stock Shares Outstanding	- 0.94	Total Current Assets
Common Stock	- 0.94	Total Liab